Role of apoptosis of vascular endothelial cells In atherosclerosis

血管内皮细胞凋亡在动脉粥样硬化中的作用

基本信息

  • 批准号:
    13470141
  • 负责人:
  • 金额:
    $ 7.1万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2003
  • 项目状态:
    已结题

项目摘要

Although the role of the calcineurin-dependent pathway in the development of cardiac hypertrophy has been intensively studied little is known of its role in vascular inflammatory diseases such as atherosclerosis and restenosis after angioplasty. To help elucidate the role of calcineurin in vascular inflammation, we infected cultured vascular smooth muscle cells (VSMCs) with an adenovirus construct expressing a constitutively active mutant of calcineurin, and examined its effect on the expression of monocyte chemoattractant protein-1 (MCP-1). We also examined the role of calcineurin in vivo using a transluminal wire injury model of the rat femoral artery. Forced activation of calcineurin significantly increased the expression of MCP-1 both at the transcriptional and protein levels, Angiotensin II (Ang II) also significantly stimulated MCP-1 expression, and this increase was significantly inhibited by cyclosporin A (CyA). Constitutive activation of calcineurin stabilized MCP-1 mRNA without enhancing MCP-1 promoter activity. In accordance with the results, Ang II-induced increase of MCP-1 promoter activity was not suppressed by CyA. Ang II stabilized MCP-1 mRNA, and this effect of Ang II was diminished by CyA. CyA suppressed MCP-1 expression in the femoral artery after the transluminal mechanical injury. CyA also inhibited macrophage Infiltration and neointimal formation in the wire-injured femoral arteries. These results suggested that calcineurin mediates vascular inflammation via stimulation of MCP-1 expression in VSMCs and macrophage infiltration.
虽然钙调神经磷酸酶依赖性通路在心肌肥厚发展中的作用已被深入研究,但其在血管炎性疾病如动脉粥样硬化和血管成形术后再狭窄中的作用知之甚少。为了帮助阐明钙调神经磷酸酶在血管炎症中的作用,我们用表达钙调神经磷酸酶组成型活性突变体的腺病毒构建体感染培养的血管平滑肌细胞(VSMCs),并研究其对单核细胞趋化蛋白-1(MCP-1)表达的影响。我们还研究了钙调神经磷酸酶在体内使用的大鼠股动脉的经腔线损伤模型的作用。钙调神经磷酸酶的强制激活显著增加MCP-1在转录和蛋白水平的表达,血管紧张素II(Ang II)也显著刺激MCP-1的表达,这种增加被环孢菌素A(CyA)显著抑制。钙调神经磷酸酶的组成性激活稳定了MCP-1 mRNA,而不增强MCP-1启动子活性。根据结果,Ang II诱导的MCP-1启动子活性的增加不被CyA抑制。Ang Ⅱ稳定MCP-1 mRNA的表达,而CyA可减弱Ang Ⅱ的这种作用。CyA抑制经腔机械损伤后股动脉MCP-1的表达。CyA还抑制了丝损伤的股动脉中的巨噬细胞浸润和新生内膜形成。这些结果表明,钙调神经磷酸酶介导的血管炎症,通过刺激MCP-1的表达在VSMCs和巨噬细胞浸润。

项目成果

期刊论文数量(76)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Sata M, Sugiura S, Yoshizumi M, Ouchi Y, Hirata Y, Nagai R: "Acute and chronic smooth muscle cell apoptosis after mechanical vascular Injury can occur independently of the fas-death pathway."Arterioscler Thromb Vasc Blob. 21. 1733-1737 (2001)
Sata M、Sugiura S、Yoshizumi M、Ouchi Y、Hirata Y、Nagai R:“机械性血管损伤后的急性和慢性平滑肌细胞凋亡可以独立于 fas 死亡途径发生。”动脉硬化血栓血管斑点。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Abe M, Sata M, Nishimatsu H, Nagata D, Suzuki E, Terauchi Y, Kadowaki T, Matsuo H, Hirata Y, Nagai R: "Adrenomedullin augments collateral development in response to acute ischemia."Biochem Biophys Res Commun. 306. 10-15 (2003)
Abe M、Sata M、Nishimatsu H、Nagata D、Suzuki E、Terauchi Y、Kadowaki T、Matsuo H、Hirata Y、Nagai R:“肾上腺髓质素增强侧枝发育以应对急性缺血。”Biochem Biophys Res Commun。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Abe M, Sofa M, Nishimatsu H, Nagata D, Suzuki E, Terauchi Y, Kadowaki T, Minamino N, Kangawa K, Matsuo H, Hirata Y, Nagai R: "Adrenomedullin augments collateral development in response t o acute ischemia."Biochem Biophys Res Commun. 306. 10-15 (2003)
Abe M、Sofa M、Nishimatsu H、Nagata D、Suzuki E、Terauchi Y、Kadowaki T、Minamino N、Kangawa K、Matsuo H、Hirata Y、Nagai R:“肾上腺髓质素增强侧枝发育以应对急性缺血。”Biochem Biophys
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nishimatsu H, Hirata Y 他: "Role of endogenous adrenomedullin in the regulation of vascular tone and ischemic renal injury : studies on transgenic/knockout mice of adrenomedullin gene."Circ Res. 90. 657-663 (2002)
Nishimatsu H、Hirata Y 等人:“内源性肾上腺髓质素在调节血管张力和缺血性肾损伤中的作用:对肾上腺髓质素基因转基因/基因敲除小鼠的研究。”Circ Res. 90. 657-663 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nishimatsu H, Hirata Y. et al.: "Role of endogenous adrenomedullin in the regulation of vascular tone and ischemic renal injury : studies on transgenic/knockout mice of adrenomedullin gene"Circ.Res.. 90. 657-663 (2002)
Nishimatsu H、Hirata Y.等:“内源性肾上腺髓质素在调节血管张力和缺血性肾损伤中的作用:对肾上腺髓质素基因转基因/敲除小鼠的研究”Circ.Res.. 90. 657-663 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HIRATA Yasunobu其他文献

HIRATA Yasunobu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HIRATA Yasunobu', 18)}}的其他基金

Development of novel therapy for atherosclerosis using adipose tissue-derived stem cells
利用脂肪组织干细胞开发动脉粥样硬化新疗法
  • 批准号:
    22590822
  • 财政年份:
    2010
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Studies on visualization of arteriosclerotic lesion using vascular cell-derived vasoactive substances
利用血管细胞源性血管活性物质对动脉硬化病变进行可视化研究
  • 批准号:
    16390217
  • 财政年份:
    2004
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Identification and regulation of differentiation In bone marrow -derived vascular progenitor cells
骨髓源性血管祖细胞分化的鉴定和调控
  • 批准号:
    13557061
  • 财政年份:
    2001
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Research on mechanisms for vascular action of adrenomedullin
肾上腺髓质素血管作用机制研究
  • 批准号:
    10218202
  • 财政年份:
    1998
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research on Priority Areas
Establishment of nitric oxide measurement in exhaled air and its clinical application.
呼出气中一氧化氮测量方法的建立及其临床应用
  • 批准号:
    09670700
  • 财政年份:
    1997
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of sensitve assay of NO and its clinical application
NO灵敏检测方法的研制及其临床应用
  • 批准号:
    07557055
  • 财政年份:
    1995
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Studies on mechanisms of atrial natriuretic peptide secretion
心房钠尿肽分泌机制的研究
  • 批准号:
    61570405
  • 财政年份:
    1986
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
  • 批准号:
    10537602
  • 财政年份:
    2023
  • 资助金额:
    $ 7.1万
  • 项目类别:
Multi-omics analysis on carotid artery stenosis for the biological mechanism of arteriosclerosis.
颈动脉狭窄的多组学分析动脉硬化的生物学机制。
  • 批准号:
    23K14718
  • 财政年份:
    2023
  • 资助金额:
    $ 7.1万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Leveraging pleiotropy to develop polygenic risk scores for cardiometabolic diseases
利用多效性开发心脏代谢疾病的多基因风险评分
  • 批准号:
    10797389
  • 财政年份:
    2023
  • 资助金额:
    $ 7.1万
  • 项目类别:
Systems Genetics of Vascular Smooth Muscle Phenotypes
血管平滑肌表型的系统遗传学
  • 批准号:
    10771623
  • 财政年份:
    2023
  • 资助金额:
    $ 7.1万
  • 项目类别:
Cardiovascular risk from comprehensive evaluation of the CT calcium score exam
CT钙评分检查综合评估心血管风险
  • 批准号:
    10853742
  • 财政年份:
    2023
  • 资助金额:
    $ 7.1万
  • 项目类别:
Whole genome sequence interpretation for lipids to discover new genes and mechanisms for coronary artery disease
脂质的全基因组序列解释,以发现冠状动脉疾病的新基因和机制
  • 批准号:
    10722515
  • 财政年份:
    2023
  • 资助金额:
    $ 7.1万
  • 项目类别:
Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease
心血管事件的分子预测因素和慢性冠状动脉疾病的恢复力
  • 批准号:
    10736587
  • 财政年份:
    2023
  • 资助金额:
    $ 7.1万
  • 项目类别:
Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism
TRIB1调节肝脏代谢的分子机制
  • 批准号:
    10660520
  • 财政年份:
    2023
  • 资助金额:
    $ 7.1万
  • 项目类别:
The Role of Arylsulfatase in Vascular Calcification
芳基硫酸酯酶在血管钙化中的作用
  • 批准号:
    10658067
  • 财政年份:
    2023
  • 资助金额:
    $ 7.1万
  • 项目类别:
Quantitative Detection of Coronary Microvascular Dysfunction in Long COVID Patients using a Comprehensive, Rapid, Free-Breathing Cardiovascular MRI
使用全面、快速、自由呼吸的心血管 MRI 定量检测长期新冠肺炎患者的冠状动脉微血管功能障碍
  • 批准号:
    10671235
  • 财政年份:
    2023
  • 资助金额:
    $ 7.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了